Article

Development of a Synthetic Poxvirus-Based SARS-CoV-2 Vaccine

2020-07-02

Abstract excerpt

Modified Vaccinia Ankara (MVA) is a highly attenuated poxvirus vector that is widely used to develop vaccines for infectious diseases and cancer. We developed a novel vaccine platform based on a unique three-plasmid system to efficiently generate recombinant MVA vectors from chemically synthesized DNA. In response to the ongoing global pandemic caused by SARS coronavirus-2 (SARS-CoV-2), we used this novel vaccine...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9027c5d0-cb12-5c68-98c8-f9a40f5ee6d8
DOI: 10.1101/2020.07.01.183236

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development of a Synthetic Poxvirus-Based SARS-CoV-2 VaccineDOI 10.1101/2020.07.01.183236Read

Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platformSemantic proximity Read

Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus PlatformSemantic proximity Read

Design and Immune Profile of Multi-Epitope Synthetic Antigen Vaccine Against SARS-CoV-2: An In Silico and In Vivo ApproachSemantic proximity Read

Rapid development of a synthetic DNA vaccine for COVID-19Semantic proximity Read

Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2Semantic proximity Read

Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA SARS 2 S in preclinical vaccinationSemantic proximity Read

Potent immunogenicity and broad-spectrum protection potential of microneedle array patch-based COVID-19 DNA vaccine candidates encoding dimeric RBD chimera of SARS-CoV and SARS-CoV-2 variantsSemantic proximity Read

Synthetic modified vaccinia Ankara vaccines confer potent monkeypox immunity in non-human primates and healthy adultsSemantic proximity Read

Extracellular vesicle-based vaccine platform displaying native viral envelope proteins elicits a robust anti-SARS-CoV-2 response in miceSemantic proximity Read

The Evolution of Poxvirus VaccinesSemantic proximity Read

MVA and NYVAC as Vaccines against Emergent Infectious Diseases and CancerSemantic proximity Read

Preclinical Study of DNA Vaccines Targeting SARS-CoV-2Semantic proximity Read